Malignant Solid Neoplasm
291
102
166
77
Key Insights
Highlights
Success Rate
82% trial completion
Published Results
36 trials with published results (12%)
Research Maturity
77 completed trials (26% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
5.8%
17 terminated out of 291 trials
81.9%
-4.6% vs benchmark
6%
18 trials in Phase 3/4
47%
36 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 77 completed trials
Clinical Trials (291)
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
The Vanguard Study: Testing a New Way to Screen for Cancer
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Increasing Knowledge and Interest in Cancer Clinical Trials
Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
Ex Vivo Expansion (ACT-X)
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer Patients
Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients
NCI COVID-19 in Cancer Patients, NCCAPS Study
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Addressing the Nutritional Needs of Cancer Survivors With Nutrition Insecurity
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Intravital Microscopy in Human Solid Tumors
The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors